Literature DB >> 11591726

Identification of sequences within the gamma-carboxylase that represent a novel contact site with vitamin K-dependent proteins and that are required for activity.

B N Pudota1, E L Hommema, K W Hallgren, B A McNally, S Lee, K L Berkner.   

Abstract

The vitamin K-dependent (VKD) carboxylase converts clusters of Glu residues to gamma-carboxylated Glu residues (Glas) in VKD proteins, which is required for their activity. VKD precursors are targeted to the carboxylase by their carboxylase recognition site, which in most cases is a propeptide. We have identified a second tethering site for carboxylase and VKD proteins that is required for carboxylase activity, called the vitamin K-dependent protein site of interaction (VKS). Several VKD proteins specifically bound an immobilized peptide comprising amino acids 343-355 of the human carboxylase (CVYKRSRGKSGQK) but not a scrambled peptide containing the same residues in a different order. Association with the 343-355 peptide was independent of propeptide binding, because the VKD proteins lacked the propeptide and because the 343-355 peptide did not disrupt association of a propeptide factor IX-carboxylase complex. Analysis with peptides that overlapped amino acids 343-355 indicated that the 343-345 CVY residues were necessary but not sufficient for prothrombin binding. Ionic interactions were also suggested because peptide-VKD protein binding could be disrupted by changes in ionic strength or pH. Mutagenesis of Cys(343) to Ser and Tyr(345) to Phe resulted in 7-11-fold decreases in vitamin K epoxidation and peptide (EEL) substrate and carboxylase carboxylation, and kinetic analysis showed 5-6-fold increases in K(m) values for the Glu substrate. These results suggest that Cys(343) and Tyr(345) are near the catalytic center and affect the active site conformation required for correct positioning of the Glu substrate. The 343-355 VKS peptide had a higher affinity for carboxylated prothrombin (K(d) = 5 microm) than uncarboxylated prothrombin (K(d) = 60 microm), and the basic VKS region may also facilitate exiting of the Gla product from the catalytic center by ionic attraction. Tethering of VKD proteins to the carboxylase via the propeptide-binding site and the VKS region has important implications for the mechanism of VKD protein carboxylation, and a model is proposed for how the carboxylase VKS region may be required for efficient and processive VKD protein carboxylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591726     DOI: 10.1074/jbc.M108696200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency.

Authors:  Dhouha Darghouth; Kevin W Hallgren; Rebecca L Shtofman; Amel Mrad; Youssef Gharbi; Ahmed Maherzi; Radhia Kastally; Sophie LeRicousse; Kathleen L Berkner; Jean-Philippe Rosa
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

2.  Characterization of vitamin K-dependent carboxylase mutations that cause bleeding and nonbleeding disorders.

Authors:  Jian-Ke Tie; Jorge D A Carneiro; Da-Yun Jin; Ciro D Martinhago; Cees Vermeer; Darrel W Stafford
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

3.  Effect of GGCX gene polymorphism on the responses of serum undercarboxylated osteocalcin and bone turnover markers after treatment with vitamin K2 (menatetrenone) among postmenopausal Thai women.

Authors:  Thawee Songpatanasilp; La-or Chailurkit; Suwannee Chantprasertyothin; Boonsong Ongphiphadhanakul; Nimit Taechakraichana
Journal:  J Bone Miner Metab       Date:  2011-02-23       Impact factor: 2.626

4.  Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements.

Authors:  Janne Cadamuro; Benjamin Dieplinger; Thomas Felder; Igor Kedenko; Thomas Mueller; Meinhard Haltmayer; Wolfgang Patsch; Hannes Oberkofler
Journal:  Eur J Clin Pharmacol       Date:  2009-12-18       Impact factor: 2.953

5.  Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population.

Authors:  Rina Kimura; Yoshihiro Kokubo; Kotaro Miyashita; Ryoichi Otsubo; Kazuyuki Nagatsuka; Toshiho Otsuki; Toshiyuki Sakata; Junko Nagura; Akira Okayama; Kazuo Minematsu; Hiroaki Naritomi; Shigenori Honda; Kiyoshi Sato; Hitonobu Tomoike; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

Review 6.  Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase.

Authors:  Mark A Rishavy; Kathleen L Berkner
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 7.  Vitamin K-Dependent Protein Activation: Normal Gamma-Glutamyl Carboxylation and Disruption in Disease.

Authors:  Kathleen L Berkner; Kurt W Runge
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

8.  Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines.

Authors:  Naoki Ueda; Hidenori Shiraha; Tatsuya Fujikawa; Nobuyuki Takaoka; Yutaka Nakanishi; Mayumi Suzuki; Noriyuki Matsuo; Shigetomi Tanaka; Shin-Ichi Nishina; Masayuki Uemura; Akinobu Takaki; Yasushi Shiratori; Kazuhide Yamamoto
Journal:  Mol Oncol       Date:  2008-06-20       Impact factor: 6.603

9.  A new model for vitamin K-dependent carboxylation: the catalytic base that deprotonates vitamin K hydroquinone is not Cys but an activated amine.

Authors:  Mark A Rishavy; B Nirmala Pudota; Kevin W Hallgren; Wen Qian; Anna V Yakubenko; Jee-Hyeon Song; Kurt W Runge; Kathleen L Berkner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

Review 10.  Structural and functional insights into enzymes of the vitamin K cycle.

Authors:  J-K Tie; D W Stafford
Journal:  J Thromb Haemost       Date:  2016-01-29       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.